低血清碳酸氢盐水平增加2型糖尿病全因、心血管疾病及癌症死亡风险
本研究基于美国国家健康与营养调查(NHANES)1999至2018年数据,纳入8163例成年2型糖尿病患者,随访至2019年12月31日。多变量调整后,较低血清碳酸氢盐水平与全因、心血管疾病及癌症死亡风险升高显著线性相关,估计肾小球滤过率变化分别解释其与全因和心血管死亡关联的12.10%和16.94%。
要点
- 较低血清碳酸氢盐水平与全因死亡风险升高40%显著相关(P < .05)。
- 较低血清碳酸氢盐水平与心血管疾病死亡风险升高48%显著相关(P < .05)。
- 较低血清碳酸氢盐水平与癌症死亡风险升高84%显著相关(P < .05)。
核心结论
- 较低血清碳酸氢盐浓度与较高的全因、心血管疾病及癌症死亡风险显著相关。
- 作者认为维持充足的碳酸氢盐状态可能降低2型糖尿病患者的死亡风险。
研究设计与样本
- 研究纳入来自美国国家健康与营养调查(NHANES)1999至2018年的8163例成年糖尿病患者。
- 死亡结局通过链接至2019年12月31日的国家死亡索引记录确定。
- 采用Cox比例风险模型估计全因、心血管疾病及癌症死亡的风险比(HR)和95% CI。
- 在反事实框架下使用逻辑回归模型评估11种代谢、心血管及肾脏生物标志物的中介效应。
主要发现
- 随访期间共记录2310例死亡,包括659例心血管疾病死亡和399例癌症死亡。
- 多变量调整后,较低血清碳酸氢盐水平与较高的全因、心血管疾病及癌症死亡风险显著线性相关:与正常组相比,全因死亡风险增加40%,心血管疾病死亡风险增加48%,癌症死亡风险增加84%(均P < .05)。
- 估计肾小球滤过率变化分别解释血清碳酸氢盐与全因死亡和心血管疾病死亡关联的12.10%和16.94%。
- 总胆固醇分别中介全因死亡和心血管疾病死亡关联的4.70%和10.51%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The evidence regarding bicarbonate status and mortality among diabetes is scarce. OBJECTIVE: The purpose of this study was to investigate the associations of bicarbonate concentrations with risk of all-cause, cardiovascular disease (CVD), and cancer mortality among patients with type 2 diabetes (T2D). METHODS: This study included 8163 adult diabetic patients from the National Health and Nutrition Examination Survey (NHANES), 1999 to 2018. Death outcomes were ascertained by linkage to National Death Index records through 31 December 2019. The Cox proportional-risk model was used to estimate hazard ratios (HR) and 95% CIs for mortality from all causes, CVD, and cancer. The mediating effects of 11 metabolic, cardiovascular, and renal biomarkers were evaluated using a logistic regression model within a counterfactual framework. RESULTS: During 8163 person-years of follow-up, 2310 deaths were documented, including 659 CVD deaths and 399 cancer deaths. After multivariate adjustment, lower serum bicarbonate levels were significantly linearly correlated with higher all-cause, CVD, and cancer mortality: The risk of all-cause death increased by 40%, the risk of CVD death increased by 48%, and the risk of cancer death increased by 84% compared with the normal group (all P < .05). Altered levels of estimated glomerular filtration rate explained 12.10% and 16.94% of the relation between serum bicarbonate with all-cause and CVD mortality, respectively. Total cholesterol mediated 4.70% and 10.51% of the associations of all-cause and CVD mortality, respectively. CONCLUSION: Lower serum bicarbonate concentrations were significantly associated with higher all-cause, CVD, and cancer mortality. These findings suggest that maintaining adequate bicarbonate status may lower mortality risk in individuals with T2D.
引用
- Li Y, Gao R, Zhao B, et al. Low Serum Bicarbonate Levels Increase the Risk of All-Cause, Cardiovascular Disease, and Cancer Mortality in Type 2 Diabetes. J Clin Endocrinol Metab. 2022. PMID: 36066477. doi:10.1210/clinem/dgac504
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。